Arjo AB (publ) (ARJO-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 33.60 |
|---|---|
| 52-week range | 23.64 – 34.30 |
| Return, 1 month / 3 months | +22.2% / +26.0% |
| Return, 1 year / 3 years | +13.2% / +5.4% |
| Trend | Uptrend |
| RSI (14) | 80 |
| Volatility (1 year) | 28.4% |
| Worst drawdown (1 year) | -23.8% |
| Average daily value traded | 10.55M SEK |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arjo is a Swedish medical technology company that supplies equipment and services to hospitals, care homes and other healthcare providers. Its products cover patient handling and mobility, including hoists and lift systems, along with hygiene and disinfection solutions, wound care products and therapy surfaces. The company also offers related services and support to help care facilities manage patient movement and infection control. Arjo is based in Sweden and serves customers across Europe and other international healthcare markets.
Arjo AB (publ) trades under the code ARJO-B on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arjo AB (publ) (ARJO-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 33.60 on 27 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 52 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.2% and over the last three months it rose 26.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.0% | ||
| From 52-week high | -1.5% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.0% | ||
| 6-month return | 34.2% | ||
| 12-month return, skipping the last month | -7.4% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.8% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 10.55M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +19.8% |
|---|---|
| 1 month | +22.2% |
| 3 months | +26.0% |
| 6 months | +34.2% |
| 1 year | +13.2% |
| 3 years | +5.4% |
| 5 years | −67.7% |
Signals
| 50-day / 200-day average | 28.40 / 26.45 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Apr 2026 | SEK 0.9500 |
| 30 Apr 2025 | SEK 0.9500 |
| 19 Apr 2024 | SEK 0.9000 |
| 21 Apr 2023 | SEK 0.8500 |
| 25 Apr 2022 | SEK 1.1500 |
| 28 Apr 2021 | SEK 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.